Sarepta price target cut in half at Baird after gene therapy setback – Seeking Alpha

https://news.google.com/__i/rss/rd/articles/CBMiZ2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9uZXdzLzM2NTAwNTYtc2FyZXB0YS1wcmljZS10YXJnZXQtY3V0LWluLWhhbGYtYmFpcmQtYWZ0ZXItZ2VuZS10aGVyYXB5LXNldGJhY2vSAWtodHRwczovL3NlZWtpbmdhbHBoYS5jb20vYW1wL25ld3MvMzY1MDA1Ni1zYXJlcHRhLXByaWNlLXRhcmdldC1jdXQtaW4taGFsZi1iYWlyZC1hZnRlci1nZW5lLXRoZXJhcHktc2V0YmFjaw?oc=5

Business - Latest - Google News

Business - Latest - Google News

1. Sarepta price target cut in half at Baird after gene therapy setback  Seeking Alpha
2. Sarepta Stock Dropped 50% After Gene-Therapy Setback. What to Do Now.  Barron's
3. Sarepta Craters, Cutting Market Value in Half on Therapy Miss  Yahoo Finance
4. Why Solid Biosciences Stock Is Sinking Today  Motley Fool
5. Sarepta Sinks on Disappointing Gene-Therapy Study Results  TheStreet
6. View Full Coverage on Google News

Related posts

• Zoom Video, Alibaba Among Most Profitable Shorts Since Election Day – Benzinga (0)
• Zoom Video prices $1.75 billion secondary offering at 5% discount – MarketWatch (0)
• Zoom Video Communications Obliterates Quarterly Earnings Estimates – Deadline (0)
• Zoom lied to users about end-to-end encryption for years, FTC says – Ars Technica (0)
• Zoom Founder Drops $5 Billion as Vaccine Hits Covid Winners – Bloomberg (0)
• Zoom and other ‘stay-at-home’ stocks got crushed on the positive vaccine news – CNBC (0)